No
Who we are
A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver
RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC
Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)